Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Janice M. Riberdy"'
Autor:
Janice M. Riberdy, Sheng Zhou, Fei Zheng, Young-In Kim, Jennifer Moore, Abishek Vaidya, Robert E. Throm, April Sykes, Natasha Sahr, Challice L. Bonifant, Byoung Ryu, Stephen Gottschalk, Mireya Paulina Velasquez
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss , Pp 571-581 (2020)
Chimeric antigen receptor (CAR) T cells targeting CD123, an acute myeloid leukemia (AML) antigen, hold the promise of improving outcomes for patients with refractory/recurrent disease. We generated five lentiviral vectors encoding CD20, which may ser
Externí odkaz:
https://doaj.org/article/00f59d1265734c9e80eae423e4fa63df
Autor:
Olga Villamizar, Christopher B. Chambers, Yin-Yuan Mo, Donald S. Torry, Reese Hofstrand, Janice M. Riberdy, Derek A. Persons, Andrew Wilber
Publikováno v:
Data in Brief, Vol 7, Iss , Pp 1288-1295 (2016)
This paper describes data related to a research article titled, “Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death” [1]. Long noncoding RNAs (lnc
Externí odkaz:
https://doaj.org/article/0c6613d8f1c54bce97d3b1df52423b59
Autor:
Paul G. Thomas, Jeremy Chase Crawford, Stephen Gottschalk, Aimee C. Talleur, Brandon M. Triplett, Michael M. Meagher, Catherine Willis, Timothy Lockey, Scott R. Olsen, Sanchit Trivedi, Pratibha Kottapalli, M. Paulina Velasquez, Janice M. Riberdy, Mikhail V. Pogorelyy, Jean-Yves Métais, E. Kaitlynn Allen, Anastasia A. Minervina, Robert C. Mettelman, Deanna Langfitt, Ching-Heng Chou, Hyunjin Kim, Taylor L. Wilson
Supplementary Data from Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022121b49237ed4e775f0ed1d50797c9
https://doi.org/10.1158/2159-8290.22541072
https://doi.org/10.1158/2159-8290.22541072
Autor:
Taylor L. Wilson, Hyunjin Kim, Ching-Heng Chou, Deanna Langfitt, Robert C. Mettelman, Anastasia A. Minervina, E. Kaitlynn Allen, Jean-Yves Métais, Mikhail V. Pogorelyy, Janice M. Riberdy, M. Paulina Velasquez, Pratibha Kottapalli, Sanchit Trivedi, Scott R. Olsen, Timothy Lockey, Catherine Willis, Michael M. Meagher, Brandon M. Triplett, Aimee C. Talleur, Stephen Gottschalk, Jeremy Chase Crawford, Paul G. Thomas
Publikováno v:
Cancer Discov
Current chimeric antigen receptor-modified (CAR) T-cell products are evaluated in bulk, without assessing functional heterogeneity. We therefore generated a comprehensive single-cell gene expression and T-cell receptor (TCR) sequencing data set using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5381811ae3546973a3dccf96f0848fe3
https://europepmc.org/articles/PMC9437573/
https://europepmc.org/articles/PMC9437573/
Autor:
Byoung Y. Ryu, Challice L. Bonifant, Jennifer Moore, Robert E. Throm, Fei Zheng, Young In Kim, Abishek Vaidya, April Sykes, Janice M. Riberdy, Stephen Gottschalk, Natasha Sahr, Sheng Zhou, Mireya Paulina Velasquez
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 571-581 (2020)
Molecular Therapy: Methods & Clinical Development, Vol 18, Iss, Pp 571-581 (2020)
Chimeric antigen receptor (CAR) T cells targeting CD123, an acute myeloid leukemia (AML) antigen, hold the promise of improving outcomes for patients with refractory/recurrent disease. We generated five lentiviral vectors encoding CD20, which may ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4de410d2b4d9d598635eb9d8c2dd5c
http://europepmc.org/articles/PMC7393323
http://europepmc.org/articles/PMC7393323
Autor:
Matthew Bell, Zhongzhen Yi, Cicera R. Lazzarotto, Christopher DeRenzo, Stephen Gottschalk, Ben Youngblood, Peter Vogel, Janice M. Riberdy, Sheng Zhou, Charmaine Brown, Shengdar Q. Tsai, Dalia Haydar, Jeremy Chase Crawford, Christopher T. Petersen, Mireya Paulina Velasquez, Jeoungeun J. Park, Shondra M. Pruett-Miller, Shanta Alli, Deanna Langfitt, Caitlin C. Zebley, Haley Houke, Giedre Krenciute, Phuong Nguyen, Yiping Fan, Brooke Prinzing, Shannon K. Boi, Alejandro Allo Anido
Publikováno v:
Sci Transl Med
Chimeric antigen receptor (CAR) T cell therapy is revolutionizing cancer immunotherapy for patients with B cell malignancies and is now being developed for solid tumors and chronic viral infections. Although clinical trials have demonstrated the cura
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d6501849907000f7810beae9ca67cdc
https://doi.org/10.1126/scitranslmed.abh0272
https://doi.org/10.1126/scitranslmed.abh0272
Autor:
Young-In Kim-Hoehamer, Janice M. Riberdy, Fei Zheng, Jeoungeun J. Park, Na Shang, Jean-Yves Métais, Timothy Lockey, Catherine Willis, Salem Akel, Jennifer Moore, Michael M. Meagher, M. Paulina Velasquez, Brandon M. Triplett, Aimee C. Talleur, Stephen Gottschalk, Sheng Zhou
Publikováno v:
Gene therapy.
Autologous chimeric antigen receptor (CAR) T cells targeting the CD19 antigen have demonstrated a high complete response rate in relapsed/refractory B-cell malignancies. However, autologous CAR T cell therapy is not an option for all patients. Here w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82c96d4beb3b395c69e01bd4315f15d
https://pubmed.ncbi.nlm.nih.gov/34997202
https://pubmed.ncbi.nlm.nih.gov/34997202
Autor:
Aimee C Talleur, Salem M. Akel, N. Shang, Paulina Velasquez, J. Park, Stephen Gottschalk, J. Moore, S. Zhou, F. Zheng, Janice M. Riberdy, Jean-Yves Metais, Y. Kim Hoehamer, Brandon M. Triplett
Publikováno v:
Cytotherapy. 23:S171-S172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f68f9d8cd166bfae1da6fb25983eddf5
https://doi.org/10.1016/s1465324921005685
https://doi.org/10.1016/s1465324921005685
Publikováno v:
Oncotarget
In multicellular organisms, cell growth and differentiation is controlled in part by programmed cell death or apoptosis. One major apoptotic pathway is triggered by Fas receptor (Fas)-Fas ligand (FasL) interaction. Neoplastic cells are frequently res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04091473beab231da5ecda5ef08c92e8
http://europepmc.org/articles/PMC4924680
http://europepmc.org/articles/PMC4924680
Autor:
Brandon M. Triplett, Deanna Langfitt, Sheng Zhou, Wenting Zheng, Byoung Y. Ryu, Paulina Velasquez, Alisha Gaboriault, Jeremy Chase Crawford, Robert E. Throm, Timothy D. Lockey, Janice M. Riberdy, Guolian Kang, Clifford A. Froelich, Terrence L. Geiger, Aimee C Talleur, Michael M Meagher, Benjamin Youngblood, Jean-Yves Metais, Amr Qudeimat, Abishek Vaidya, Stephen Gottschalk, Catherine Willis, Paul G. Thomas
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a843fd0a9a461f4e0b14908754c3846
https://doi.org/10.1016/j.clml.2019.07.186
https://doi.org/10.1016/j.clml.2019.07.186